T1	Concept 0 8	SARS-CoV
T2	Action 33 39;40 42	depend on
T3	Concept 80 91	Ca 2+ pools
T4	Concept 80 91	Ca 2+ pools
T5	Concept 48 61	extracellular
T6	Concept 66 79	intracellular
R1	has-property Arg1:T3 Arg2:T6	
R2	has-property Arg1:T4 Arg2:T5	
R3	subject Arg1:T2 Arg2:T1	
R4	target Arg1:T2 Arg2:T3	
R5	target Arg1:T2 Arg2:T4	
T7	Action 107 116	infection
R6	causes Arg1:T2 Arg2:T7	
T8	Concept 168 173	Ca 2+
T9	Action 174 186;187 191	interactions with
T10	Concept 196 204	SARS-CoV
T11	Concept 205 207	FP
R7	in-context Arg1:T11 Arg2:T10	
R8	subject Arg1:T9 Arg2:T8	
R9	target Arg1:T9 Arg2:T11	
R10	causes Arg1:T9 Arg2:T2	
T12	Action 261 268	wearing
T13	Concept 252 260	facemask
R11	target Arg1:T12 Arg2:T13	
T14	Concept 302 316	cost-effective
T15	Concept 242 250	measures
T16	Concept 222 233	respiratory
T17	Concept 234 241	hygiene
R12	in-context Arg1:T15 Arg2:T17	
R13	in-context Arg1:T17 Arg2:T16	
T18	Concept 321 330	important
T19	Concept 331 339	measures
R15	has-property Arg1:T19 Arg2:T18	
R16	has-property Arg1:T19 Arg2:T14	
R17	is-a Arg1:T12 Arg2:T19	
T20	Action 355 367	transmission
R18	causes Arg1:T19 Arg2:T20	
A1	Negated T20
T21	Concept 371 381	SARS-CoV-2
R19	subject Arg1:T20 Arg2:T21	
R20	is-a Arg1:T19 Arg2:T15	
T22	Concept 505 520	interferon-MAPK
T23	Concept 521 530;531 538	signaling pathway
R14	in-context Arg1:T23 Arg2:T22	
T24	Action 487 497	activation
R21	target Arg1:T24 Arg2:T23	
T27	Concept 551 554	BCR
T25	Concept 543 546	TCR
T28	Concept 563 573	antibodies
R22	is-a Arg1:T27 Arg2:T28	
R23	is-a Arg1:T25 Arg2:T28	
T26	Action 592 601	combating
A2	Emphasized T26
T29	Action 613 622	infection
T30	Concept 602 612	SARS-CoV-2
R24	subject Arg1:T29 Arg2:T30	
R25	target Arg1:T26 Arg2:T29	
R26	subject Arg1:T26 Arg2:T24	
R27	subject Arg1:T26 Arg2:T25	
R28	subject Arg1:T26 Arg2:T27	
T31	Concept 698 702	data
T32	Concept 689 697	official
R29	has-property Arg1:T31 Arg2:T32	
T33	Action 710 719	diffusion
T34	Concept 723 733	SARS-CoV-2
R30	subject Arg1:T33 Arg2:T34	
R31	in-context Arg1:T31 Arg2:T33	
T35	Action 735 746;747 749	responsible of
T36	Concept 765 772	disease
T37	Concept 774 782	COIVD-19
R32	is-a Arg1:T37 Arg2:T36	
R33	subject Arg1:T35 Arg2:T34	
R34	target Arg1:T35 Arg2:T37	
T38	Concept 846 850	bias
T39	Concept 830 836	strong
T40	Concept 837 845	downward
R35	has-property Arg1:T38 Arg2:T40	
R36	has-property Arg1:T38 Arg2:T39	
T41	Action 816 822	suffer
A3	Emphasized T41
A4	Uncertain T41
R37	target Arg1:T41 Arg2:T38	
R38	subject Arg1:T41 Arg2:T31	
T42	Concept 869 879	SARS-CoV-2
T43	Concept 855 865	antibodies
R39	in-context Arg1:T43 Arg2:T42	
T44	Concept 884 892	specific
T45	Concept 894 903	sensitive
R40	has-property Arg1:T43 Arg2:T44	
R41	has-property Arg1:T43 Arg2:T45	
T46	Action 933 942	detection
T47	Concept 955 961	faster
T48	Concept 966 973	simpler
R42	target Arg1:T46 Arg2:T43	
R43	has-property Arg1:T46 Arg2:T47	
R44	has-property Arg1:T46 Arg2:T48	
T49	Concept 979 985	RT-PCR
R45	in-context Arg1:T48 Arg2:T49	
R46	in-context Arg1:T47 Arg2:T49	
T50	Action 1006 1015	screening
T51	Concept 1019 1026;1027 1032	suspect cases
R47	target Arg1:T50 Arg2:T51	
T52	Concept 1000 1005	rapid
R48	has-property Arg1:T50 Arg2:T52	
R49	causes Arg1:T46 Arg2:T50	
